Literature DB >> 3191589

Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction.

A K Ellis1, T Little, A R Masud, H A Liberman, D C Morris, F J Klocke.   

Abstract

Myoglobin (Mb) is a protein that enters rapidly and is rapidly cleared from plasma after coronary reperfusion. We sought to determine the accuracy with which a rapid rise in plasma [Mb] could predict successful coronary artery reopening in patients undergoing coronary arteriography in conjunction with attempted reperfusion in acute myocardial infarction. In 42 patients, plasma Mb levels were measured before and for at least 4 hours after attempted reperfusion. Thirty-five patients were successfully reperfused. In each, the plasma Mb level rose rapidly with peak [Mb] occurring at 111 +/- 8.1 (+/- SEM) minutes after application of therapy. In contrast, Mb levels rose more slowly in the seven patients who were not reperfused, with peak [Mb] occurring 360 +/- 61.4 minutes after attempted reperfusion. T25-100 (the time required for [Mb] to rise from 25% to 100% of peak value) was shorter in patients successfully reperfused (71 +/- 7.9 minutes) and longer (341 +/- 35.3 minutes) in patients in whom therapy was unsuccessful. A rapid rise in [Mb] after successful reperfusion was also evident by a more than 4.6-fold rise in [Mb] over the first 2 hours after reperfusion in all but five patients; in contrast, [Mb] rose by less than 4.6-fold over this same interval in every patient not successfully reperfused (sensitivity, 85%; specificity, 100%; predictive accuracy, 88%). We conclude that a rapid rise in plasma Mb level over the initial 2 hours after attempted reperfusion in acute myocardial infarction provides a useful index of successful reperfusion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191589     DOI: 10.1161/01.cir.78.6.1352

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Cardiology.

Authors:  L D Smith; D J Coltart
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

2.  Evaluation of coronary artery patency using cardiac markers.

Authors:  Milenko J Tanasijevic
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

3.  Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction.

Authors:  K Yoshimoto; T Tanaka; K Somiya; R Tsuji; F Okamoto; K Kawamura; Y Ohkaru; K Asayama; H Ishii
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 4.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

5.  Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels.

Authors:  R M Norris; R N Johnson; H D White; D R Robinson
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

6.  Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.

Authors:  M J de Groot; A M Muijtjens; M L Simoons; W T Hermens; J F Glatz
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

7.  Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin.

Authors:  J Mair; E Artner-Dworzak; P Lechleitner; B Morass; J Smidt; I Wagner; F Dienstl; B Puschendorf
Journal:  Br Heart J       Date:  1992-11

Review 8.  An historical approach to the diagnostic biomarkers of acute coronary syndrome.

Authors:  Elisa Danese; Martina Montagnana
Journal:  Ann Transl Med       Date:  2016-05

9.  Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.

Authors:  J F Glatz; A H Kleine; F A van Nieuwenhoven; W T Hermens; M P van Dieijen-Visser; G J van der Vusse
Journal:  Br Heart J       Date:  1994-02

10.  Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.

Authors:  M Tubaro; G Mattioli; F Matta; C Cappello; E Natale; R Ricci; P Gerardi; F Milazzotto
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.